NEW YORK (GenomeWeb News) – Illumina said today that its board of directors has approved a new stock buy-back program that authorizes the firm to repurchase up to $75 million of its outstanding common stock.

Illumina said that it has terminated a previously announced $120 million repurchase program after repurchasing $70.7 million of outstanding common stock in 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.